Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
29.79
+1.12 (3.91%)
At close: Jun 26, 2026, 4:00 PM EDT
29.70
-0.09 (-0.32%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Oscar Health Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Oscar Health stock have an average target of 20, with a low estimate of 13 and a high estimate of 35. The average target predicts a decrease of -32.86% from the current stock price of 29.79.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Oscar Health stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 2 | 2 | 2 | 3 |
| Hold | 6 | 5 | 5 | 6 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 2 | 2 | 2 | 1 | 1 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Upgrades $30 → $35 | Buy | Upgrades | $30 → $35 | +17.49% | Jun 11, 2026 |
| Wells Fargo | Wells Fargo | Hold Upgrades $11 → $20 | Hold | Upgrades | $11 → $20 | -32.86% | Jun 4, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Reiterates $17 → $22 | Hold | Reiterates | $17 → $22 | -26.15% | May 11, 2026 |
| Robert W. Baird | Robert W. Baird | Hold Maintains $15 → $19 | Hold | Maintains | $15 → $19 | -36.22% | May 7, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $11 → $13 | Sell | Maintains | $11 → $13 | -56.36% | May 7, 2026 |
Financial Forecast
Revenue This Year
18.55B
from 11.70B
Increased by 58.50%
Revenue Next Year
19.79B
from 18.55B
Increased by 6.70%
EPS This Year
1.06
from -1.69
EPS Next Year
1.48
from 1.06
Increased by 40.28%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.9B | 21.7B | |
| Avg | 18.5B | 19.8B | |
| Low | 17.2B | 15.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 61.8% | 17.2% | |
| Avg | 58.5% | 6.7% | |
| Low | 46.6% | -17.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.38 | 2.00 | |
| Avg | 1.06 | 1.48 | |
| Low | 0.63 | 1.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 89.0% | |
| Avg | - | 40.3% | |
| Low | - | -5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.